Heparin in inflammation: potential therapeutic applications beyond anticoagulation.
about
Heparin's anti-inflammatory effects require glucosamine 6-O-sulfation and are mediated by blockade of L- and P-selectinsHeparin and cancer revisited: mechanistic connections involving platelets, P-selectin, carcinoma mucins, and tumor metastasisHeparan sulfate signaling in cancerLow-dose intravenous heparin infusion in patients with aneurysmal subarachnoid hemorrhage: a preliminary assessment.Stepwise inhibition of T cell recruitment at post-capillary venules by orally active desulfated heparins in inflammatory arthritisHeparin oligosaccharides as potential therapeutic agents in senile dementiaAntithrombotic therapy in cardiac embolism.Heparin therapy reduces 28-day mortality in adult severe sepsis patients: a systematic review and meta-analysis.Unfractionated heparin: multitargeted therapy for delayed neurological deficits induced by subarachnoid hemorrhage.The physiologic and therapeutic role of heparin in implantation and placentation.Therapeutic effects of pyrrolidine dithiocarbamate on acute lung injury in rabbits.Some structural determinants of the antiproliferative effect of heparin-like molecules on human airway smooth muscleOpposing effects of low molecular weight heparins on the release of inflammatory cytokines from peripheral blood mononuclear cells of asthmatics.Tissue factor, blood coagulation, and beyond: an overview.A nonerythropoietic peptide that mimics the 3D structure of erythropoietin reduces organ injury/dysfunction and inflammation in experimental hemorrhagic shock.In-vitro suppression of IL-6 and IL-8 release from human pulmonary epithelial cells by non-anticoagulant fraction of enoxaparinNon-Anticoagulant Fractions of Enoxaparin Suppress Inflammatory Cytokine Release from Peripheral Blood Mononuclear Cells of Allergic Asthmatic Individuals.Heparin-induced leukocytosis requires 6-O-sulfation and is caused by blockade of selectin- and CXCL12 protein-mediated leukocyte trafficking in mice.Inhibition of allergic airway responses by heparin derived oligosaccharides: identification of a tetrasaccharide sequence.Graphene Functionalized Scaffolds Reduce the Inflammatory Response and Supports Endogenous Neuroblast Migration when Implanted in the Adult BrainInhibition of IκB Kinase Attenuates the Organ Injury and Dysfunction Associated with Hemorrhagic ShockDelivery of therapeutic levels of heparin and low-molecular-weight heparin through a pulmonary route.Effects of low molecular weight heparin on platelet surface P-selectin expression and serum interleukin-8 production in rats with trinitrobenzene sulphonic acid-induced colitis.Abnormal function of platelets and role of angelica sinensis in patients with ulcerative colitisHeparin and structurally related polymers attenuate eotaxin-1 (CCL11) release from human airway smooth muscle.Treatment of severe sepsis: where next? Current and future treatment approaches after the introduction of drotrecogin alfa.Syndecan-1 is an in vivo suppressor of Gram-positive toxic shockBench-to-bedside review: Citrate for continuous renal replacement therapy, from science to practice.Doxorubicin-induced vascular toxicity--targeting potential pathways may reduce procoagulant activityA Heparin-Mimicking Block Copolymer Both Stabilizes and Increases the Activity of Fibroblast Growth Factor 2 (FGF2).Syndecan-1 shedding facilitates the resolution of neutrophilic inflammation by removing sequestered CXC chemokines.HEPBURN - investigating the efficacy and safety of nebulized heparin versus placebo in burn patients with inhalation trauma: study protocol for a multi-center randomized controlled trial.Heparan sulfate-protein binding specificity.Inhibition of Toll-Like Receptor Signaling as a Promising Therapy for Inflammatory Diseases: A Journey from Molecular to Nano Therapeutics.The effects of heparin on the adhesion of human peripheral blood mononuclear cells to human stimulated umbilical vein endothelial cells.Necessity of heparin for maintaining peripheral venous catheters: A systematic review and meta-analysis.Size-fractionated heparins have differential effects on human neutrophil function in vitro.Effects of heparin and related molecules upon neutrophil aggregation and elastase release in vitro.The effects of heparin and related molecules on vascular permeability and neutrophil accumulation in rabbit skin.The Role of Heparan Sulfate in Inflammation, and the Development of Biomimetics as Anti-Inflammatory Strategies.
P2860
Q24552437-0EB9B04D-DD94-43F6-BEA3-2120348D0B17Q24630993-B2A1200A-60E2-4E0C-B428-84CC59536A0CQ28657828-F721C598-3EE7-4974-950D-02DACEDB6280Q33410310-0D526A96-35D1-4EA6-A853-840971ACE00DQ33574588-070F849A-1C09-4AFC-A1D5-6CC90A96F938Q33965772-529218C7-927A-4F3F-AA67-478C60A400F9Q34362901-EF09114E-80F1-4BE6-AC15-0224960C8B23Q34423049-A2451B45-0D75-48B8-AE00-E6EBBE8F96B7Q34448852-24381CDB-E50A-4C2B-8300-B47D8AE2FD8DQ35007371-E64D2277-3FB9-426D-A292-2EF6601572D8Q35038581-516DDB43-4054-424C-AF47-6BFE1627CA1DQ35049186-0A70E299-C97F-448E-B3AF-EC9C9BAC62F4Q35147247-8C7FAAD3-DD52-414F-9927-0DE353A9A2A3Q35222618-556F3FB5-82DE-4273-AEB2-7DA761EBB981Q35287077-5565BA8E-76EC-4AA4-AF0D-9288A0C75526Q35626866-3B658C92-BA82-4EB6-9B16-D76D49897517Q35653704-90D45DFD-C251-41BA-B18F-D826C9022373Q35774009-D4DD9017-8DCF-4E97-BD1B-844BE819847AQ35812192-0DD16A40-CE41-4F17-BF78-FDFC49DD66FAQ35957660-20370040-732C-49EF-A9C8-2A98F147B117Q36167076-5562D586-1C35-4249-9402-EE602EB08B56Q36449216-808AB147-272E-4D60-97E7-9492F03DF91CQ36474174-515BCA08-E677-41DE-988B-985B5E7AE4F6Q36474332-318CF996-9FC1-4A53-9A65-5658614BC748Q36736317-7249BB57-AD10-4FE1-91E6-189B59770158Q36744024-486F2304-1C1B-4DAB-A96F-9B7071A61146Q36761832-AB34F741-D765-4C09-902C-416FDB62E594Q36902584-BC1DC008-83EA-40FD-AF31-0D675EA322BFQ37188135-EE4CD81A-07C8-4BA3-8613-2D7A030E2588Q37330610-FF36F2BB-391E-4749-BF3B-3118CD07EF89Q37373049-4EC8DD4F-CE86-4418-B57C-230A6FE8B52FQ37704781-E152BBF3-B6AE-42D8-AA4E-071A8D2291CEQ38134808-E700BC84-15BD-482D-BEAC-950B707F545CQ38557048-03D7A21E-9040-4782-B6D0-AC879FCD790DQ40774057-624C028A-949F-442A-9A2D-29E3F2451BBCQ41116729-35E0AB58-5868-4621-A658-CD7D0F5D0CECQ41590603-2FFB7FFC-35A5-4876-8267-B66CECD299B4Q41935530-22317F24-6359-4A55-AB02-4F512BBC9D00Q42082826-B65E24A1-6FCE-44B5-8151-101634639261Q47207922-DEF71B91-639B-4782-812F-4226404951F2
P2860
Heparin in inflammation: potential therapeutic applications beyond anticoagulation.
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Heparin in inflammation: potential therapeutic applications beyond anticoagulation.
@ast
Heparin in inflammation: potential therapeutic applications beyond anticoagulation.
@en
type
label
Heparin in inflammation: potential therapeutic applications beyond anticoagulation.
@ast
Heparin in inflammation: potential therapeutic applications beyond anticoagulation.
@en
prefLabel
Heparin in inflammation: potential therapeutic applications beyond anticoagulation.
@ast
Heparin in inflammation: potential therapeutic applications beyond anticoagulation.
@en
P2093
P1476
Heparin in inflammation: potential therapeutic applications beyond anticoagulation
@en
P2093
P304
P356
10.1016/S1054-3589(08)60471-8
P577
1999-01-01T00:00:00Z